Global Liposomes Drug Delivery Market Study 2015-2025, by Segment (Liposomal doxorubicin, Liposomal Amphoteracin B, Liposomal Paclitaxel), by Market (Fungal Infection Therapy, Cancer Therapy ( Tumor therapy)Liposomal Amphoteracin B, Others), by Company (Johnson & Johnson, Gilead Sciences, Luye Pharma)
ReportPage
Report ID
44976
Published Date
25-Sep
No of Report Page
79
Report Category
Pharmaceuticals and Healthcare
Editor's Rating
US $3,600.00
US $3,600.00
US $1,800.00

  • Report Details 
    Snapshot
    
Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only. In a liposome drug product, the drug substance
    More...
  • Table Of Content 
    Table of Content
    
1 Industry Overview
    
    1.1 Liposomes Drug Delivery Industry
    
        1.1.1 Overview
    
        1.1.2 Products of Major Companies
    
    1.2 Market Segment
    
        1.2.1 Industry Chain
    
        1.2.2 Consumer Distribution
    
    1.3 Price & Cost Overview
    
2 Liposomes Drug Delivery Market by Type
    
    2.1 By Type
    
       2.1.1 Liposomal doxorubicin
    
       2.1.2 Liposomal Amphoteracin B
    
       2.
    More...
  • Inquiry Before Buying
    Inquiry Before Buying -
  • Request Sample
    Request For Sample
portalmarketdeskus
 
Survey No. 3/1,4/1/3 Rajwade Commercial Complex Office No. 8, Phase 2 Behind SBI Bank, Pune - Bengaluru Hwy, Ambegaon BK, Pune, Maharashtra 411046
Navigation : -
Connect with Us : -
Secured Payment Options : -